Dermacia genetic research
14 January, 2006
Dermacia forms research and development subside
Capitalizing on its research to date for active ingredients and complexes for customized skin care products and pharmaceuticals based on a consumer's individual DNA, Dermacia Inc. has formed a biomedical research and development subsidiary, National Genecular Institute, Inc., to focus on new technologies related to specific genes affecting the skin and skin aging.
In making the announcement today, Matt Nicosia, Dermacia's chief executive officer and co-founder, also announced that noted molecular and cell biologist and research scientist Dr. Tannin Fuja will direct all scientific research for National Genecular Institute, Inc.
Research at National Genecular Institute is in the areas of nanotechnology applications, molecular genetics of the skin, and skin diseases and conditions.
We will be able to produce products that are so precisely matched to the individual's skin needs as to address even genetic skin factors of which the customer is unaware because the associated skin problems have not yet manifested themselves.
Its mission is to facilitate biomedical research that is pursuing advances in identifying human genetic factors affecting the skin and formulating products and therapies to target issues specific to the individual customer, both for prevention and treatment.
NGI is studying the effects of both intrinsic (genetic background) and extrinsic (environmental impact) molecular components as they relate to skin characteristics and aging.
"This is a vast new market -- both in terms of filling a true void for consumers and in economic potential for pioneering companies like Dermacia and National Genecular Institute."
Dr. Fuja, an accomplished molecular geneticist, comes to NGI from the University of Iowa, where he has served as head of the Molecular and Cell Biology Group of the National Center for Voice and Speech.
The term "cosmeceutical" denotes the rapidly growing market for cosmetics and skin care products formulated to provide therapeutic benefits and active ingredients to the user in addition to color and coverage.